title: The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders.
abstract: Our 15 years of research have generated the first short- and long-term efficacy data for speech treatment (Lee Silverman Voice Treatment; LSVT/LOUD) in Parkinson's disease. We have learned that training the single motor control parameter amplitude (vocal loudness) and recalibration of self-perception of vocal loudness are fundamental elements underlying treatment success. This training requires intensive, high-effort exercise combined with a single, functionally relevant target (loudness) taught across simple to complex speech tasks. We have documented that training vocal loudness results in distributed effects of improved articulation, facial expression, and swallowing. Furthermore, positive effects of LSVT/LOUD have been documented in disorders other than Parkinson's disease (stroke, cerebral palsy). The purpose of this article is to elucidate the potential of a single target in treatment to encourage cross-system improvements across seemingly diverse motor systems and to discuss key elements in mode of delivery of treatment that are consistent with principles of neural plasticity.
authors.affiliation: Research Associate, National Center for Voice and Speech, Denver, CO Research Lecturer, Department of Neurology, University of Arizona, Tucson, Arizona.
authors.forename: Cynthia M
authors.initials: CM
authors.lastname: Fox
authors.forename: Lorraine O
authors.initials: LO
authors.lastname: Ramig
authors.forename: Michelle R
authors.initials: MR
authors.lastname: Ciucci
authors.forename: Shimon
authors.initials: S
authors.lastname: Sapir
authors.forename: David H
authors.initials: DH
authors.lastname: McFarland
authors.forename: Becky G
authors.initials: BG
authors.lastname: Farley
mesh_terms: D003680:Deglutition Disorders / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D009422:Nervous System Diseases / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D009473:Neuronal Plasticity / Q000502:physiology*; D010300:Parkinson Disease / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D013061:Speech Acoustics; D013070:Speech Therapy / Q000379:methods*; D016896:Treatment Outcome; D014827:Vocal Cords / Q000473:pathology; D014832:Voice Disorders / Q000209:etiology / Q000628:therapy*; D014834:Voice Training